Final Program and Oral Abstracts [International Conference on AIDS (8th: 1992: Amsterdam, Netherlands)]

THURSDAY, 23 JULY 1992 14.30-16.00

SESSIONS

SESSION 167

SESSION 168

Thursday, 23 July 1992
Time: 14.30-16.00
Lecture room: Al
Session title: REVERSE TRANSCRIPTION & INTEGRATION
Oral Abstract
Chairperson: Brendan Larder (UNITED KINGDOM)
Abstract #

Thursday, 23 July 1992
Time: 14.30-16.00
Lecture room: A2
Session title: T-CELL REPERTOIRE & HIV INFECTION
Oral Abstract
Chairperson: A. Benslimane (MOROCCO)
Abstract #

14.30
THREE-DIMENSIONAL STRUCTURE OF HIV-1
REVERSE TRANSCRIPTASE COMPLEXED WITH A
DSDNA TEMPLATE-PRIMER REVEALS
ARRANGEMENT OF THE ACTIVE SITES FOR
POLYMERIZATION AND RNASE
Arnold, Edward*; Jacobo-Molina, A.*; Nanni, R.G.*;
Williams, R.L.*; Clark, A.D., JR*; Ding, J.*; Lu, X.*;
*CABM & Rutgers University; Piscataway; UNITED
STATES
14.40
THE SECOND ORIGIN OF HIV DNA PLUS-STRAND:
STRUCTURE AND ROLE IN VIRAL REPLICATION
Clavel, Francois*; Charneau, P.*; *Unite d'Oncologie
Virale, Inst. Pasteur; Paris; FRANCE
14.50
THE CENTRAL POLYPURINE TRACT IN THE HIV-1
GENOME IS IMPORTANT FOR VIRAL REPLICATION
Grinde, Bjorn*; Jonsrud, K.*; Tjotta, E.*; Hungnes, O.*;
*National Institute of Public Health; Oslo; NORWAY
15.00
PREFERENCE FOR G->A HYPERMUTATION VIA
DISLOCATION MUTA-GENESIS BY THE HIV-1
REVERSE TRANSCRIPTASE
Vartanian, Jean-Pierre*; Meyerhans, A.*; Sala, M.*;
Buc, H.*; Henry, M.*; Wain-Hobson, S.*; *Laboratoire
de Retrovirologie Moleculaire, Institut Pasteur; Paris;
FRANCE
15.10
FEATURES GOVERNING NUCLEAR IMPORT OF HIV-1
PREINTEGRATION COMPLEXES: ROLE IN
PERMISSIVENESS, LATENCY AND REACTIVATION
Stevenson, Mario*; Bukrinsky, M.I.*; Sharova, N.**;
Gulizia, J.*; Haggerty, S.*; *University of Nebraska
Medical Center; Omaha; UNITED STATES; **D.I.
Ivanovsky Institute of Virology; Moscow; RUSSIA
15.20
DISCUSSANT
To Be Announced

14.30
ThA 1531 INFLUENCE OF HIV INFECTION ON THE VB
REPERTOIRE IN MONOZYGOTIC TWINS DISCORDANT
FOR HIV: EVIDENCE FOR THE EFFECTS OF A
SUPERANTIGEN
Pantaleo, Giuseppe*; Rebai, N.**; Graziosi, C.***;
Lane, H.C.***; Sekaly, R.P.***; Fauci, A.S.*; *LIR,
NIAID; Bethesda; UNITED STATES; **Lab.
Immunology, IRCM; Montreal; CANADA; ***LIR,
NIAID, NIH; Bethesda
14.40
ThA 1532 POSITIVE SELECTION OF THE VB5 TCR GENE
PRODUCT IN HIV INFECTED INDIVIDUALS
Wilson, Susan*; Gompels, M.**; Ludlam, C.**; Coates,
A.*; Habeshaw, J.***; Dalgleish, A.G.*; *St. George's
Hospital Medical School; London; UNITED KINGDOM;
**Edinburgh Royal Infirmary; Edinburgh; ***HIVER
ThA 1533 Ltd.; London
14.50
HIV-1 ACTS AS A SUPERANTIGEN: TCR VB
EXPRESSION REGULATES HIV REPLICATION
Laurence, Jeffrey*; Hodtsev, A.S.*; Posnett, D.N.*;
ThA 1534 *Cornell University Medical College; New York;
UNITED STATES

ThA 1536
ThA 1537
ThA 1538
ThA 1539
ThA 1540

ThA 1535

15.00
BIASED T-CELL RECEPTOR VB REPERTOIRE OF
PERIPHERAL BLOOD DERIVED AND INTESTINAL CD8
T-CELLS IN HIV DISEASE
Deusch, Kai*; Dahne, I.*; Endres, N.*; Reich, K.*;
Poppinger, J.**; Jager, H.**; Classen, M.*; *Technical
University of Munich; Munich; GERMANY;
**Curatorium for Immunodeficiency
15.10
T-CELL RECEPTOR V GENE EXPRESSION ON CD4+
AND CD8+ PERIPHERAL T CELLS FROM HIV+
PATIENTS
Hodara, Vida L.*; Jeddi-Tehrani, M.*; Grunewald, J.*;
Anderson, R.*; Scarlatti, G.**; Holmberg, V.***;
Libonatti, O.****; Et Al.; *Karolinska Institute;
Stockholm; SWEDEN; **Virology National
Bacteriological Lab.; ***Venhalsan, South Hospital;
**** Dept. Microbiology, University of Buenos Aires;
Buenos Aires; ARGENTINIA

222